See the website here!

For Tellus Fonder, we developed a completely new website with a modern structure and a user-friendly CMS, enabling the team to independently update content, publish news, and manage fund information without technical dependencies.

As part of the project, we also created a dedicated landing page for the Midas Fund, designed with a clear focus on retail investors. The structure and content were tailored to make it easy to understand the fund’s strategy, risk profile, and performance — providing visitors with a clear and accessible basis for evaluating the investment.

The result is a scalable platform that combines clear communication, conversion-focused structure, and full editorial control.

View the landing page here!

For Active Biotech, we were responsible for strategy, positioning, and digital execution in connection with the company’s rights issue, which was subscribed to approximately 82.8% and raised around SEK 70.3 million before issuance costs.

We are particularly proud of the emissions landing page we developed — a clear, educational, and decision-driven page that generated very strong engagement during the subscription period.

Through continuous optimization of messaging, channels, and structure, we drove qualified traffic while also gathering valuable insights into investor behavior for future capital raises.

‍

For Immunovia, we were responsible for strategy, positioning, and digital execution in connection with the company’s rights issue of approximately SEK 100 million. The issue was subscribed to approximately 87.9% with and without subscription rights, and the remaining 12.1% was allocated to guarantors, resulting in the issue being fully subscribed at 100%. The company thereby raised approximately SEK 100 million before issuance costs.

We developed a clear and decision-driven emissions landing page that generated strong engagement, with a large share of visitors staying on the page and actively consuming the content during the subscription period.

Through continuous optimization of messaging, channels, and structure, we drove qualified traffic while gathering valuable insights into investor behavior for future capital raises.

View the landing page  here!

View the landing page here!

For Isofol Medical, we designed a data-driven marketing strategy ahead of and during the company’s rights issue, which concluded with an oversubscription of approximately 120%. We selected relevant channels, produced advertising materials, and optimized the landing page with a clear conversion logic. In parallel, we analyzed channel performance, messaging, and investor behavior through A/B testing and segmentation.

The work generated concrete insights into which target groups engaged, which channels drove subscriptions, and what information influenced investment decisions.

See the landing page here!

For Saniona, we were responsible for strategy, positioning, and digital execution in connection with the exercise of the TO4 warrants. Approximately 97.6% of the warrants were exercised, and together with a directed issue to top guarantors, the company raised approximately SEK 115 million before issuance costs.

We developed a clear and conversion-focused landing page that generated strong engagement during the exercise period, with a large share of visitors staying on the page and actively engaging with the content before making their investment decision.

Through continuous optimization of messaging, structure, and channels, we drove qualified traffic while gathering valuable insights into investor behavior for future capital raises.

Velvic developed a marketing strategy for Immunovia’s TO3 warrants, building on the previous work we carried out in connection with the rights issue. We selected relevant channels, produced advertising materials, and updated the landing page for the offer.

A comprehensive data analysis was conducted, measuring ROI across different channels and messages, and running A/B tests on advertisements. We also gained valuable insights into the engaged investor audience — which channels they used and what type of information different segments were most interested in on the landing page.

Se landningssidan här!

We led Noba Bank’s IPO preparations in close collaboration with their team, overseeing the design, development, and launch of their IR website. Acting as both project managers and strategic advisors, we ensured everything adhered to strict regulatory requirements and exceeded industry standards. Our focus on quality, collaboration, and compliance helped establish Noba as a credible presence on the public market.

Velvic developed a marketing strategy for Agtira’s rights issue. We selected relevant channels, created ad materials, and conducted a data analysis of the campaign results.

Velvic developed a marketing strategy for Immunovia’s TO2 series warrants, building on the previous campaign we ran for their rights issue.

We selected relevant channels, created ad materials, and updated the offer’s landing page. A comprehensive data analysis was conducted, where we measured the ROI of different channels and messages, and A/B tested ads.

We also gained valuable insights into the interested investor audience—what channels they used and which information different segments found most engaging on the landing page.
‍

See the landing page here!

‍

Velvic developed a marketing strategy for Immunovia's rights issue, where we selected relevant channels, created advertising materials, and developed a modern and user-friendly landing page for the offer.

A comprehensive data analysis was conducted, measuring the ROI for various channels, messages, and A/B tested ads. We also gained valuable insights into the interested investor target groups, the channels they used, and which information different segments were most interested in on the landing page.

See the landing page here!

Velvic developed a comprehensive marketing strategy and created customized communication materials for carefully selected channels, with the aim of communicating the offer of Moberg Pharma's warrants during the spring and summer of 2024.

An in-depth data analysis was conducted to provide insights into the investor target groups and to evaluate the effectiveness of the campaign's messages and channels. The result was a subscription rate of 98%.

Velvic developed a marketing strategy, created advertising materials, and conducted an in-depth data analysis of the campaigns to give Scandion Oncology a better understanding of their investor target group. See the landing page here!

We conducted an in-depth analysis of Calliditas' Investor Relations page, focusing on traffic and user behavior to identify opportunities for improvement. This analysis revealed areas where investors were not achieving their goals or finding the information they sought, along with data outliers and reactions to report releases. We delivered a clear understanding of the website’s performance and valuable insights into the investor target group.

We assisted WntResearch with the marketing strategy for their rights issue by creating a comprehensive marketing plan and a digital advertising strategy based on insights from our database of previous marketing strategies.

We also developed a user-friendly landing page that gathered all the necessary information about the issue in one place. The landing page enabled us to track the performance of all channels and measure how well visitors converted into subscribers for the offer.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Ortoma's rights issue. We gained many new insights into the ROI of marketing mailings, channels, and campaigns for the issue.

See the landing page here.

We created a new visual language and a new website for Cord Communications in under a month. Cord Communications is a partner-owned communications advisor with a focus on IR and financial PR.

It was a fast, smooth, and enjoyable project. See Cord Communications' website here.

Together with our partner, Shark Communication, we helped develop a refreshed visual identity for Alzinova in connection with their rights issue and created a landing page to present the offer. This led to increased engagement from visitors, and we are very pleased with the result.

Here is the landing page we created for the issue.

In collaboration with Shark Communication, we created a landing page to represent Stayble's rights issue. We gained valuable new insights into the ROI of marketing mailings, channels, and campaigns for the issue. The rights issue was subscribed to 90%.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Spotlight's rights issue. The issue was oversubscribed by 161%.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Audientes' rights issue, which was subscribed to 100%.

See the landing page here.

In collaboration with Shark Communication, we created a website to represent Safeture's rights issue. The issue was oversubscribed by 106%.

See the landing page here.

‍Lokon Pharma entrusted us with the task of creating a website that would clearly and engagingly present the company to the world. We designed and developed an entirely new website from the ground up, making their industry-specific research expertise easy to understand. At the same time, we explained their research process and made it easy for patients to sign up for ongoing studies. See the new website here.